Sinco Pharmaceuticals Holdings Limited provided earnings guidance for the year ended 31 December 2019. the group is expected to record a consolidated net profit of approximately RMB 22 million to RMB 32 million for the Current Period, as compared to a consolidated net loss of approximately RMB 280.6 million for the year ended 31 December 2018.